{"entity":{"type":"insider","cik":"0001586785","url":"/insider/0001586785","json_url":"/insider/0001586785.json","name":"NEIL GARRY ARTHUR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2014-12-02","last":"2023-06-13","span_basis":"filed_date"},"name_variants":[{"name":"NEIL GARRY ARTHUR","source":"filing","n_filings":10,"first_seen":"2014-12-02","last_seen":"2023-06-13"}],"transactions":[{"id":7983132,"accession":"0001628280-23-021958","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-021958","line_url":"/filing/0001628280-23-021958#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":3.42,"price_display":"3.42","price_state":"stated","total_value":13680.0,"total_display":"13,680.00","total_whole":"13,680","shares_owned_after":13220.0,"shares_owned_after_display":"13,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-13","scope":"insider"},{"id":6733151,"accession":"0001628280-22-031725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-031725","line_url":"/filing/0001628280-22-031725#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2083.0,"shares_display":"2,083","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":9206.86,"total_display":"9,206.86","total_whole":"9,207","shares_owned_after":9220.0,"shares_owned_after_display":"9,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-12","scope":"insider"},{"id":4581968,"accession":"0001879785-21-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001879785-21-000037","line_url":"/filing/0001879785-21-000037#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4267.0,"shares_display":"4,267","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":6699.19,"total_display":"6,699.19","total_whole":"6,699","shares_owned_after":85639.0,"shares_owned_after_display":"85,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-14","scope":"insider"},{"id":4656151,"accession":"0001192482-21-000501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-21-000501","line_url":"/filing/0001192482-21-000501#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3692.0,"shares_display":"3,692","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":8417.76,"total_display":"8,417.76","total_whole":"8,418","shares_owned_after":81372.0,"shares_owned_after_display":"81,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-14","scope":"insider"},{"id":2151352,"accession":"0001192482-20-000816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000816","line_url":"/filing/0001192482-20-000816#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3599.0,"shares_display":"3,599","price_per_share":2.278,"price_display":"2.28","price_state":"stated","total_value":8198.522,"total_display":"8,198.52","total_whole":"8,199","shares_owned_after":77680.0,"shares_owned_after_display":"77,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-14","scope":"insider"},{"id":2528087,"accession":"0001192482-20-000484","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000484","line_url":"/filing/0001192482-20-000484#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1799.0,"shares_display":"1,799","price_per_share":2.278,"price_display":"2.28","price_state":"stated","total_value":4098.122,"total_display":"4,098.12","total_whole":"4,098","shares_owned_after":74081.0,"shares_owned_after_display":"74,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-11","scope":"insider"},{"id":8554685,"accession":"0001192482-19-000511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-19-000511","line_url":"/filing/0001192482-19-000511#line-1","is_derivative":false,"issuer_cik":"0001138776","issuer_name":"Aevi Genomic Medicine, Inc.","issuer_ticker":"GNMX","issuer_name_source":null,"issuer_url":"/issuer/0001138776","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2049376.0,"shares_display":"2,049,376","price_per_share":0.134,"price_display":"0.13","price_state":"stated","total_value":274616.384,"total_display":"274,616.38","total_whole":"274,616","shares_owned_after":2164150.0,"shares_owned_after_display":"2,164,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-05","filed_date":"2019-12-09","scope":"insider"},{"id":4789504,"accession":"0001144204-17-053027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-053027","line_url":"/filing/0001144204-17-053027#line-1","is_derivative":false,"issuer_cik":"0001138776","issuer_name":"Aevi Genomic Medicine, Inc.","issuer_ticker":"GNMX","issuer_name_source":null,"issuer_url":"/issuer/0001138776","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":94500.0,"total_display":"94,500.00","total_whole":"94,500","shares_owned_after":114774.0,"shares_owned_after_display":"114,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-17","filed_date":"2017-10-18","scope":"insider"},{"id":8609008,"accession":"0001144204-15-058680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-058680","line_url":"/filing/0001144204-15-058680#line-1","is_derivative":false,"issuer_cik":"0001138776","issuer_name":"MEDGENICS, INC.","issuer_ticker":"MDGN","issuer_name_source":null,"issuer_url":"/issuer/0001138776","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15384.0,"shares_display":"15,384","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":99996.0,"total_display":"99,996.00","total_whole":"99,996","shares_owned_after":39774.0,"shares_owned_after_display":"39,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-06","filed_date":"2015-10-08","scope":"insider"},{"id":6378906,"accession":"0001144204-14-071751","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-071751","line_url":"/filing/0001144204-14-071751#line-1","is_derivative":false,"issuer_cik":"0001138776","issuer_name":"MEDGENICS, INC.","issuer_ticker":"MDGN","issuer_name_source":null,"issuer_url":"/issuer/0001138776","owner_cik":"0001586785","owner_name":"NEIL GARRY ARTHUR","owner_display_name":"NEIL GARRY ARTHUR","owner_url":"/insider/0001586785","role":"Officer (Global Head of R&D)","role_mark":"O","role_mark_label":"Officer (Global Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Global Head of R&D","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24390.0,"shares_display":"24,390","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":99999.0,"total_display":"99,999.00","total_whole":"99,999","shares_owned_after":24390.0,"shares_owned_after_display":"24,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001534120","name":"Avalo Therapeutics, Inc.","url":"/issuer/0001534120","role":"Director, Officer (CEO and Chairman of the Board)","n_filings":6,"first_seen":"2020-06-11","last_seen":"2023-06-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001138776","name":"Aevi Genomic Medicine, Inc.","url":"/issuer/0001138776","role":"Officer (Chief Scientific Officer)","n_filings":4,"first_seen":"2014-12-02","last_seen":"2019-12-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586785","retrieved_at":"2026-08-26T06:36:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}